Kojin Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Kojin Therapeutics is a biotechnology research company based in Boston, Massachusetts. The organization focuses on exploring cell-state transitions and ferroptosis biology to discover first-in-class treatments aimed at cancer, autoimmune and inflammatory diseases, and related disorders. Its work centers on a drug-discovery platform that integrates multiple scientific disciplines to identify therapeutics capable of modulating ferroptosis, a distinct mechanism of cell death. The company positions itself within the biotechnology and life sciences sector by pursuing mechanism-driven pharmacology and target-informed screening to advance novel therapeutic candidates. In addition to its research focus, Kojin emphasizes a leadership team with expertise across chemical biology, genetics, immunology, cancer therapeutics, drug discovery, and clinical development. A notable recent development is Kojin’s reported progress in developing treatments that leverage programmed cell death, as noted in early 2025 coverage. The firm is small in scale, located in the Boston area, and is part of the broader landscape of biotechnology companies advancing cell-death–related therapies.
1-888-653-2347 
support@leadiq.com 
